Update: Detection of West Nile virus in blood donations--United States, 2003.

نویسندگان

  • J Epstein
  • J Goodman
  • M Chamberland
  • M Kuehnert
  • J Roehrig
  • N Crall
  • A Marfin
چکیده

should educate health-care providers to recognize unusual illnesses that might indicate release of a chemical agent. Strategies for responding to intentional chemical releases include (1) providing information or reminders to health-care providers and clinical laboratories; (2) encouraging reporting of acute poisonings to local poison control centers, which can guide patient management and facilitate notification of the proper health agencies, and to the local or state health department; (3) initiating surveillance for incidents that potentially involve the covert release of a chemical agent; (4) implementing the capacity to receive and investigate any report of such an event; (5) implementing appropriate protocols, including potentially accessing the Laboratory Response Network for Bioterrorism, to collect and transport specimens and to store them appropriately before laboratory analysis; (6) reporting immediately to CDC and local law enforcement if the results of an investigation suggest the intentional release of a chemical agent; and (7) requesting CDC assistance when necessary. To begin developing national surveillance capabilities for detecting chemical-release–related illnesses, CDC is collaborating with the American Association of Poison Control Centers to use its Toxic Exposure Surveillance System to identify index cases, evolving patterns, or emerging clusters of hazardous exposures. Identification of early markers for chemical releases (e.g., characteristic symptom complexes, temporal and regional increases in hospitalizations, or sudden increases in case frequency or severity) will enable public health authorities to respond quickly and appropriately to an intentional chemical release. CDC materials for emergency and health-care personnel, including a list of chemical agents and biologic toxins and their expected clinical syndromes, are available at http://www.bt.cdc.gov/agent /agentlistchem.asp. Additional information about responding to chemical attacks is available from the U.S. Army Medical Research and Materiel Command at http://www.biomedtraining.org /progmat.htm, the U.S. Army Medical Research Institute of Chemical Defense at http://ccc.apgea.army.mil, and CDC and the Agency for Toxic Substances and Disease Registry at http: //www.atsdr.cdc.gov/mhmi.html.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

West Nile Virus Infections Projected from Blood Donor Screening Data, United States, 2003

National blood donor screening for West Nile virus (WNV) RNA using minipool nucleic acid amplification testing (MP-NAT) was implemented in the United States in July 2003. We compiled national NAT yield data and performed WNV immunoglobulin M (IgM) testing in 1 WNV-epidemic region (North Dakota). State-specific MP-NAT yield, antibody seroprevalence, and the average time RNA is detectable by MP-N...

متن کامل

Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.

BACKGROUND National blood donation screening for West Nile virus (WNV) started in June 2003, after the documentation of WNV transfusion-associated transmission (TAT) in 2002. STUDY DESIGN AND METHODS Blood donations were screened with investigational nucleic acid amplification assays in minipool formats. Blood collection agencies (BCAs) reported screening results to state and local public hea...

متن کامل

Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010–2012

Over the past decade, West Nile virus (WNV) has spread across the United States. We aggregated blood donor data from 2010-2012 and then calculated the incidence of WNV RNA-positive donations and compared the incidence with neuroinvasive disease (NID) case data from the ArboNET surveillance system. Of 10,107,853 donations, 640 were confirmed positive. The seasonal WNV incidence rate per 100,000 ...

متن کامل

Fatal West Nile Virus Infection After Probable Transfusion-Associated Transmission — Colorado, 2012

West Nile virus (WNV) is transmitted to humans primarily by infected mosquitoes. However, WNV also can be transmitted through infected blood products or solid organs (1). Since 2003, the U.S. blood supply has been routinely screened for WNV RNA. The Food and Drug Administration (FDA) recommends that blood collection agencies perform WNV nucleic acid testing (NAT) year-round on all blood donatio...

متن کامل

Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002.

BACKGROUND The West Nile virus (WNV) epidemic in 2002 in the US saw over 3300 reported human cases of WNV disease, with over 2300 reported cases of WNV encephalitis and meningitis. The first documented cases of transfusion transmission of WNV through voluntary blood donation also occurred. STUDY DESIGN AND METHODS Case onset dates from the 2002 WNV epidemic in the US were used to estimate the...

متن کامل

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

West Nile virus (WNV) was detected in the United States in 1999, has reoccurred every summer since, and has become endemic. Transfusion transmission was documented in 2002, and screening of blood donations for WNV began in 2003. We investigated genetic variation of WNV in human isolates obtained from specimens collected from 30 infected blood donors who tested positive for WNV RNA during 2002-2...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • MMWR. Morbidity and mortality weekly report

دوره 52 38  شماره 

صفحات  -

تاریخ انتشار 2003